ACTIVE

OCULUX

Export PDF
Financial year 2025 · closed on 31/12/2025
Gross margin
597,1 k €
-23.7% YoY
Equity
150 k €
0.0% YoY
Workforce
7,5 ETP
+23.0% YoY

What does OCULUX do?

OCULUX is a Private limited company incorporated in 2023. Its main activity is: Specialist medical practice activities. Its registered office is in Bree. It employs on average 7,5 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0803.897.002
Incorporation
12/07/2023
Legal form
Private limited company
Registered office
Witte Torenwal 9 box A1
3960 Bree · FlandreSee on map
Contributed capital
150 000,00 €
Latest accounts
31/12/2025
Average workforce
7,5 ETP
Activities (NACE)
86220Specialist medical practice activities· main86220Specialist medical practice activities
Joint committees (1)
  • 330
Signals
ProfitablePositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 2 financial years

20252024
Income statement
Gross margin597,1 k €782,1 k €
EBITDA185,5 k €272,9 k €
Operating result31,4 k €53,7 k €
Balance sheet
Equity150 k €150 k €
Total assets1,4 M €1,7 M €
Cash752,9 k €899,4 k €
Debts1,2 M €1,5 M €
Other
Workforce7,5 ETP6,1 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active

Active mandates

ASPR

Director · since 01 juillet 2023 · 0721.974.364

Represented by Sofie Le Piane

Active
Dr. Leen Clijsters

Director · since 01 juillet 2023 · 0751.888.966

Represented by Leen Clijsters

Active
At this address

Other companies at this address

CompanyCBE no.
Dr. Leen Clijsters● Active
0751.888.966
Annual accounts

Full financial information

20252024
Type of accountAbridged modelAbridged model
Start of the financial year01/01/202501/07/2023
Closing of the financial year31/12/202531/12/2024
Length of the financial year12 months18 months
Filing date23/06/202624/07/2025
General meeting26/05/202626/05/2025
Currency of the financial yearEUREUR
NBB quality labelSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

2 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202526/05/202623/06/2026DutchPDF
Abridged model31/12/202426/05/202524/07/2025DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active

Active mandates

ASPR

Director · since 01 juillet 2023 · 0721.974.364

Represented by Sofie Le Piane

Active
Dr. Leen Clijsters

Director · since 01 juillet 2023 · 0751.888.966

Represented by Leen Clijsters

Active
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other17/07/2023
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025
  2. 2024
    Annual accounts 2024
  3. 12/07/2023
    IncorporationPrivate limited company